Molecular and cellular mechanisms of apolipoprotein E4 neurotoxicity and potential therapeutic strategies
- PMID: 17002223
Molecular and cellular mechanisms of apolipoprotein E4 neurotoxicity and potential therapeutic strategies
Abstract
Apolipoprotein (apo) E is a multifunctional protein that has central roles in lipid metabolism and neurobiology. It has three common isoforms (apoE2, apoE3 and apoE4) that have different effects on lipid and neuronal homneostasis. Unlike apoE3, tie most common isoform, apoE4 is a major risk factor for Alzheimer's disease (AD). Although the mechanisms underlying the actions of apoE4 in AD pathogenesis are still poorly understood, emerging data strongly suggest that apoE4, with its multiple cellular origins and multiple structural and biophysical properties, contributes to this disease by interacting with different factors through various pathways. Thus, multiple molecular and cellular mechanisms should be considered in developing anti-AD drugs that target apoE4.
Similar articles
-
Apolipoprotein E and Alzheimer disease.Neurology. 2006 Jan 24;66(2 Suppl 1):S79-85. doi: 10.1212/01.wnl.0000192102.41141.9e. Neurology. 2006. PMID: 16432152
-
Mechanisms linking apolipoprotein E isoforms with cardiovascular and neurological diseases.Curr Opin Lipidol. 2010 Aug;21(4):337-45. doi: 10.1097/MOL.0b013e32833af368. Curr Opin Lipidol. 2010. PMID: 20531185 Review.
-
Abeta-independent roles of apolipoprotein E4 in the pathogenesis of Alzheimer's disease.Trends Mol Med. 2010 Jun;16(6):287-94. doi: 10.1016/j.molmed.2010.04.004. Epub 2010 May 27. Trends Mol Med. 2010. PMID: 20537952 Review.
-
The pathological cross talk between apolipoprotein E and amyloid-beta peptide in Alzheimer's disease: emerging gene-based therapeutic approaches.J Alzheimers Dis. 2010;21(1):35-48. doi: 10.3233/JAD-2010-100009. J Alzheimers Dis. 2010. PMID: 20182014 Review.
-
Roles of apolipoprotein E4 (ApoE4) in the pathogenesis of Alzheimer's disease: lessons from ApoE mouse models.Biochem Soc Trans. 2011 Aug;39(4):924-32. doi: 10.1042/BST0390924. Biochem Soc Trans. 2011. PMID: 21787325
Cited by
-
Intron-3 retention/splicing controls neuronal expression of apolipoprotein E in the CNS.J Neurosci. 2008 Feb 6;28(6):1452-9. doi: 10.1523/JNEUROSCI.3253-07.2008. J Neurosci. 2008. PMID: 18256266 Free PMC article.
-
Metabolomic Identification in Cerebrospinal Fluid of the Effects of High Dietary Cholesterol in a Rabbit Model of Alzheimer's Disease.Metabolomics (Los Angel). 2012 Mar 29;2(3):109. Metabolomics (Los Angel). 2012. PMID: 24851192 Free PMC article.
-
Cholesterol retention in Alzheimer's brain is responsible for high beta- and gamma-secretase activities and Abeta production.Neurobiol Dis. 2008 Mar;29(3):422-37. doi: 10.1016/j.nbd.2007.10.005. Epub 2007 Nov 4. Neurobiol Dis. 2008. PMID: 18086530 Free PMC article.
-
GABAergic interneuron dysfunction impairs hippocampal neurogenesis in adult apolipoprotein E4 knockin mice.Cell Stem Cell. 2009 Dec 4;5(6):634-45. doi: 10.1016/j.stem.2009.10.015. Cell Stem Cell. 2009. PMID: 19951691 Free PMC article.
-
Cellular source of apolipoprotein E4 determines neuronal susceptibility to excitotoxic injury in transgenic mice.Am J Pathol. 2010 Aug;177(2):563-9. doi: 10.2353/ajpath.2010.090973. Epub 2010 Jul 1. Am J Pathol. 2010. PMID: 20595630 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Medical
Miscellaneous